Drug Shortage Report for VASOPRESSIN INJECTION USP

Last updated on 2022-09-28 History
Report ID 158050
Drug Identification Number 02247938
Brand name VASOPRESSIN INJECTION USP
Common or Proper name VASOPRESSIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) VASOPRESSIN
Strength(s) 20UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size 5ML 1LIVI
ATC code H01BA
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-18
Estimated end date 2022-09-30
Actual end date 2022-09-27
Shortage status Resolved
Updated date 2022-09-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2022-09-28 English Compare
v17 2022-09-27 French Compare
v16 2022-09-27 English Compare
v15 2022-09-21 French Compare
v14 2022-09-21 English Compare
v13 2022-08-19 French Compare
v12 2022-08-19 English Compare
v11 2022-08-18 French Compare
v10 2022-08-18 English Compare
v9 2022-07-22 French Compare
v8 2022-07-22 English Compare
v7 2022-06-17 French Compare
v6 2022-06-17 English Compare
v5 2022-05-24 French Compare
v4 2022-05-24 English Compare
v3 2022-04-06 French Compare
v2 2022-04-06 English Compare
v1 2022-04-06 English Compare

Showing 1 to 18 of 18